LexDanaLexDanabeta
Inventor

Olga M. Fryszman

Inventor
San Diego, CA, US

Overview

6→
Patents
1995–2013
Patent span
Human necessities
Primary field (CPC A)

Patents· 6 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations50%
C07DHeterocyclic compounds33%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium17%
PatentTitleYear
8,580,838'5-membered heterocycle-based p38 kinase inhibitors'20138,410,160'5-membered heterocycle-based P38 kinase inhibitors'20138,242,117'5-membered heterocycle-based p38 kinase inhibitors'20127,863,314'5-membered heterocycle-based p38 kinase inhibitors'20115,543,542'Methods of preparing .alpha.-phosphonosulfinate squalene synthetase inhibitors'19965,447,922'.alpha.-phosphonosulfinic squalene synthetase inhibitors'1995

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1995–1996Based in Princeton, NJ, US· patent location history
2011–2013Patents assigned to NOVARTIS AG (4)· patent assignee history
2011–2013Based in San Diego, CA, US· patent location history
2012–2013Patents assigned to CHANG EDCON (2)· patent assignee history
2012–2013Patents assigned to FANG YUNFENG (2)· patent assignee history
2012–2013Patents assigned to FRYSZMAN OLGA M (2)· patent assignee history
2012–2013Patents assigned to LAN JIONG (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
NOVARTIS AG42011–2013
CHANG EDCON22012–2013
FANG YUNFENG22012–2013
FRYSZMAN OLGA Mself22012–2013
LAN JIONG22012–2013
Locations
LocationPatentsSpan
San Diego, California, US42011–2013
Princeton, New Jersey, US21995–1996